Novartis to transfer OTC products to Alcon

25 October 2017 - Deborah Wilkes

Archived

Novartis is transferring several ophthalmic OTC products to its Alcon eyecare division with effect from 1 January 2018. The news comes as the Swiss healthcare company carries out a strategic review of Alcon.

Click tags below for more information on topics:

Alcon

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: